Hubify (ASX:HFY) grows its EBITDA by over 300%

Nick Sundich Nick Sundich, July 18, 2023

ICT and cybersecurity services provider Hubify (ASX:HFY) impressed its shareholders with a trading update on Tuesday morning. Unaudited results depict record revenues and EBITDA more than quadrupling!

 

SIGN UP FOR THE STOCKS DOWN UNDER NEWSLETTER NOW!

 

Hubify appears to have had a strong FY23

Hubify has released unaudited results for FY23. The company’s revenues from customers only increased by 8% but it nonetheless recorded a record with $25.7m.

EBITDA was only $1m but appears to be $4.4m in FY23, representing 342% growth! Cash at bank more than doubled from $2.7m to $5.6m and the company retains its debt-free status. The company credited the result to the continued take-up of managed and professional services as well as generating synergies from past acquisitions.

 

Good growth expected in FY24

Hubify told investors that it expected a good year in FY24. If reported the expansion of enterprise customer offerings in business IT, Cloud services, IT infrastructure and cybersecurity as well as strong customer demand for both. It also hinted at further M&A activity in the months ahead.

 

Stocks Down Under Concierge is here to help you pick winning stocks!

The team at Stocks Down Under have been in the markets since the mid-90s and we have gone through many ups and downs. We have written about every sector!

Our Concierge BUY and SELL service picks the best stocks on ASX. We won’t just tell you what to buy – we give you a buy range, price target and stop loss level in order to maximise total returns. And we will only recommend very high conviction stocks where substantial due diligence has been conducted.

Our performance is well ahead of the ASX200 and All Ords.

You can try out Concierge for 3 monthsfor FREE.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

There’s no credit card needed – the trial expires automatically.

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Trump vs. Jerome Powell

Trump vs. Jerome Powell: What Happens to the Market If Powell Is Fired?

The relationship between President Donald Trump and Federal Reserve Chair Jerome Powell has often been tumultuous, particularly around decisions regarding…

Telix Pharmaceuticals on the Nasdaq

Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!

What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…

anti woke ETFs

Anti Woke ETFs: Do they practice what they preach and have they outperformed since Trump’s return to power?

Have you ever heard of so-called ‘Anti Woke ETFs’? If you’re sick of companies that are big on ESG, this…